SCHEMBL30008122

SCHEMBL30008122

O=C(O)c1cccc(-c2ccccc2OCc2ccccc2)c1[N+](=O)[O-]

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 7/20 0.64
MCL1 Q07820 1/20 0.53
CTSV O60911 2/20 0.52
CTSL P07711 2/20 0.52
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
ALDH1A1 P00352 1/20 0.49
RXRA P19793 1/20 0.49
RXRB P28702 1/20 0.49
RXRG P48443 1/20 0.49
HPD P32754 3/20 0.47
HTT P42858 1/20 0.47
DHODH Q02127 1/20 0.47
PTGER4 P35408 1/20 0.46
PTGER3 P43115 1/20 0.46
PTGER2 P43116 1/20 0.46
SGMS2 Q8NHU3 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2986814 0.89 HPD (0.57) PTGER1CTSVCTSLMEN1KMT2A
SCHEMBL10592190 0.81 PTGER1 (0.71) PTGER1MCL1RXRARXRBRXRG
SCHEMBL29574585 0.81 PKM (0.51) MCL1KMT2AALDH1A1HTT
SCHEMBL9671326 0.80 HPD (0.54) PTGER1CTSVCTSLMEN1KMT2A
SCHEMBL15013285 0.80 MAPT (0.55) MEN1KMT2AALDH1A1HPD
SCHEMBL9254298 0.80 TSHR (0.55) MEN1KMT2AALDH1A1
SCHEMBL2991148 0.79 HTT (0.53) CTSVCTSLMEN1KMT2AALDH1A1
SCHEMBL26604443 0.78 KMT2A (0.54) PTGER1CTSVCTSLMEN1KMT2A
SCHEMBL30662860 0.78 KMT2A (0.54) PTGER1CTSVCTSLMEN1KMT2A
SCHEMBL27502058 0.78 CTSV (0.48) PTGER1CTSVCTSLMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107021928-B Eltrombopag intermediate, preparation method and application thereof 常州制药厂有限公司 2022-11-18 CN claimed
CN-116874428-B PNPO inhibitor with multiple myeloma resisting effect, and preparation method and application thereof 南京中医药大学 2025-01-28 CN disclosed
CN-116874428-A PNPO inhibitor with multiple myeloma resisting effect, and preparation method and application thereof 南京中医药大学 2023-10-13 CN disclosed
CN-107021928-B Eltrombopag intermediate, preparation method and application thereof 常州制药厂有限公司 2022-11-18 CN disclosed